Avantor (AVTR)

NYSE Health Care Life Sciences Tools & Services S&P MidCap 400
$15.47
+0.33 (+2.18%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$0.50
Diluted, last four reported quarters

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Oct 28, 2026Sep/2026$0.21$0.22+4.8%

Our record of AVTR's reports since we began tracking; it grows each quarter.

Latest results, in brief

All AVTR 8-K briefs →
Oct 28, 6:08 AM ET

Avantor Q3 net sales rise 4.6% to $1,698.3 million; raises 2026 guidance

Positive earnings 2.02

Avantor reported third-quarter 2026 net sales of $1,698.3 million, up 4.6% from a year earlier, and returned to year-over-year growth. GAAP diluted EPS was $0.30 versus a loss of $1.04 in the prior-year quarter, which included a $785.0 million goodwill impairment, and the company raised its fiscal 2026 organic revenue growth and free cash flow guidance. Adjusted EPS was flat at $0.22, and adjusted EBITDA fell to $256.9 million from $267.9 million.

  • Net sales $1,698.3 million, up 4.6% (5.2% organic); VWR Distribution & Services organic growth 5.8%
  • GAAP diluted EPS $0.30 vs. $(1.04) a year earlier; adjusted EPS $0.22, unchanged
  • Fiscal 2026 organic revenue growth guidance raised to +0.75% to +1.25% from -0.5% to +0.5%; free cash flow guidance raised to $525 million to $550 million
  • Free cash flow for the quarter was $156.2 million; total gross debt was $3,699.7 million at September 30, 2026
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$1.70B+4.6% $0.30— $203.40M12.0%
Jun 2026$1.69B+0.5% $0.06-33.3% $38.10M2.3%
Mar 2026$1.58B+0.0% $0.06-33.3% $43.30M2.7%
Dec 2025$1.66B-1.4% $0.08-89.0% $52.40M3.1%
Sep 2025$1.62B-5.3% $-1.04-1400.0% -$711.80M-43.8%
Jun 2025$1.68B-1.1% $0.09-35.7% $64.70M3.8%
Mar 2025$1.58B-5.9% $0.09+0.0% $64.50M4.1%
Dec 2024$1.69B-2.1% $0.73+421.4% $500.40M29.7%

From Avantor's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$6.55B-3.4% $-0.78-175.0%-8.1%
FY2024$6.78B-2.6% $1.04+121.3%10.5%
FY2023$6.97B-7.3% $0.47-53.5%4.6%
FY2022$7.51B+1.7% $1.01+18.8%9.1%
FY2021$7.39B+15.5% $0.85+844.4%7.8%

Frequently asked questions

When is Avantor's next earnings date?

Avantor has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Avantor earn last quarter?

For the quarter ended Sep 2026, Avantor reported diluted EPS of $0.30 on revenue of $1.70B (+4.6%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.